Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

Recurrent attempts to lose weight should be avoided, study suggests

Individuals who had repeatedly attempted to lose weight had higher body mass index than those without prior weight loss attempts, according to a recent study from the University of Eastern Finland.

8 Jun 2022

Study offers insights into genetic factors that affect immunological responses in type 1 diabetes

New insights into how genetic factors affect the body's immune response in type 1 diabetes have been published in eLife.

7 Jun 2022

Study: Weight-loss surgery reduces cancer incidence and deaths

Individuals with obesity were at least two times more likely to develop certain types of cancer and 3.5 times more likely to die from from the disease than those who had weight-loss surgery, according to a new study presented here today at the American Society for Metabolic and Bariatric Surgery Annual Meeting.

7 Jun 2022

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

California is diving into the prescription drug business, attempting to achieve what no other state has done: produce its own brand of generic insulin and sell it at below-market prices to people with diabetes like Sabrina Caudillo.

7 Jun 2022

New analytical method sheds light on enduring mystery about type 2 diabetes

Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't.

6 Jun 2022

Diabetes drug's target protein can be a candidate for the treatment of Alzheimer's disease

Mechanisms associated with a particular diabetes drug can also help to protect against Alzheimer's disease, a study by researchers at Karolinska Institutet in Sweden and published in Neurology reports.

3 Jun 2022

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Researchers looked into the role played by the accessory proteins using synthetic genomics assembly technology

2 Jun 2022

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Breast cancer and type 2 diabetes would seem to be distinctly different diseases, with commonality only in their commonality.

30 May 2022

Environmental pollutants may be the reason behind development of type 1 diabetes

The environmental pollutants we consume are probably the reason why some people develop type 1 diabetes. Even low concentrations of such pollutants can result in cells producing less insulin, reveals a new study from the University of Oslo.

30 May 2022

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Researchers quantify the outcomes of pregnancies complicated by gestational diabetes.

30 May 2022

Vitamin D supplements have no clinically meaningful effect in people at high risk of type 2 diabetes

Daily vitamin D supplements do not seem to prevent the development of type 2 diabetes in people already at high risk of the condition, finds a trial from Japan published by The BMJ today.

26 May 2022

Ketamine uses a previously unknown pathway to produce an antidepressant effect, study finds

For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and do not work for more than one in three patients.

26 May 2022

Robust biomarker panel could help predict gestational diabetes in early pregnancy

UCLA researchers have taken the initial step in identifying what may be an effective way to detect gestational diabetes mellitus (GDM) earlier in pregnancy, potentially improving diagnosis and treatment for what is the most common disorder of pregnancy.

25 May 2022

Normal brain aging accelerated by 26% in people with progressive type 2 diabetes, study shows

Scientists have demonstrated that normal brain aging is accelerated by approximately 26% in people with progressive type 2 diabetes compared with individuals without the disease, reports a study published today in eLife.

24 May 2022

The Sheri and Les Biller Family Foundation's $10 million gift will support City of Hope’s supportive care program for cancer patients

City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, has received a $10 million gift from The Sheri and Les Biller Family Foundation.

24 May 2022

Insulin News and Research

Further Reading

Recurrent attempts to lose weight should be avoided, study suggests

Study offers insights into genetic factors that affect immunological responses in type 1 diabetes

Study: Weight-loss surgery reduces cancer incidence and deaths

California wants to slash insulin prices by becoming a drugmaker. Can it succeed?

New analytical method sheds light on enduring mystery about type 2 diabetes

Diabetes drug's target protein can be a candidate for the treatment of Alzheimer's disease

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Environmental pollutants may be the reason behind development of type 1 diabetes

Researchers investigate gestational diabetes mellitus and its association with maternal and fetal outcomes

Vitamin D supplements have no clinically meaningful effect in people at high risk of type 2 diabetes

Ketamine uses a previously unknown pathway to produce an antidepressant effect, study finds

Robust biomarker panel could help predict gestational diabetes in early pregnancy

Normal brain aging accelerated by 26% in people with progressive type 2 diabetes, study shows

The Sheri and Les Biller Family Foundation's $10 million gift will support City of Hope’s supportive care program for cancer patients

Widely used Type 2 diabetes drug does not prevent breast cancer spread, landmark trial finds

Tribal pharmacy dispenses free meds and fills gaps for Native Americans in the city

A digital twin for your immune system

Medication, lifestyle intervention effective in preventing Type 2 diabetes, but not cardiovascular disease

Pioneering study could transform the treatment landscape for babies with infantile spasms

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News